Study S002226

A Phase IV Placebo-controlled Single Center Trial for Tirzepatide in Idiopathic Intracranial Hypertension Trial (TIIHT)

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07191873
Acronym: TIIHT
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: QUADRUPLE
Status: RECRUITING
Enrollment: 60
Start: 2026-08-25
Primary completion: 2027-08
Lead sponsor: Duke University
Conditions: Idiopathic Intracranial Hypertension (IIH)
Interventions: DRUG:Tirzepatide; DRUG:Tirzepatide Placebo
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Change in intracranial pressure in Idiopathic Intracranial Hypertension (IIH) patients [From enrollment to end of treatment at 12 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.